Rhinitis and asthma: One airway, one disease;Rinitis y asma: Una vía respiratoria, una enfermedad

Archivos de Bronconeumologia

Volumn 41, Issue 10, 2005, Pages 569-578

  Serrano, C ^a   Valero, A ^a   Picado, C ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID;

ASTHMA; BRONCHUS; HUMAN; INFLAMMATION; NOSE; OTITIS MEDIA; PHYSIOLOGY; RESPIRATORY TRACT DISEASE; REVIEW; RHINITIS;

EID: 27844481584     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13079841     Document Type: Review

References (71)

1. Bousquet J, Van Cauwenberge P, Khaltaev N. ARIA Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108 Suppl 5:147-334.
2. Bachert C, Vignola A, Gevaert P, Leynaert B, Van Cawenberge P, Bousquet J. Allergic rhinitis, rhinosinusitis and asthma: one airway disease. Immunol Allergy Clin N Am. 2004;24:19-43.
3. Valero AL. Valoración de la obstrucción nasal. En: Valero AL, Mullol J, editores. Técnicas de exploración y diagnóstico nasal y sinusal. Barcelona: MRA Ediciones; 2003. p. 71-94.
4. Leynaert B, Neukirch F, Demoly P, Bousquet J. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Cclin Immunol. 2000;106:201-5.
5. Beasley R, Keil U, Von Mutius E, Pearce N. World wide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema: ISAAC. Lancet. 1998;351:1225-32.
6. Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol. 1999;104:301-4.
7. Gaga M, Lambrou P, Papageorgiou N, Koulouris N, Kosmas E, Fragakis S, et al. Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin Exp Allergy. 2000;30:663-9.
8. Wright AL, Holberg CJ, Martinez FD, Halonen M, Morgan W, Taussig LM. Epidemiology of physician-diagnosed allergic rhinitis in childhood. Pediatrics. 1994;94:895-901.
9. Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc. 1994;15:21-5.
10. Guerra S, Sherrill DL, Martínez FD, Barbee RA. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol. 2002;109:419-25.
11. Peat JK, Salome CM, Woolcock AJ. Longitudinal changes in atopy during a 4-year period: relation to bronchial hyperresponsiveness and respiratory symptoms in a population sample of Australian schoolchildren. J Allergy Clin Immunol. 1990;85:65-74.
12. Celedon JC, Soto-Quiros ME, Hanson LA, Weiss ST. The relationship among markers of allergy, asthma, allergic rhinitis, and eczema in Costa Rica. Pediatr Allergy Immunol. 2002;13:91-7.
13. Strohl KP, Decker MJ, Olson LG, Flak TA, Hoekje PL. The nasal response to exercise and exercise induced bronchoconstriction in normal and asthmatic subjects. Thorax. 1988;43:890-5.
14. Shturman-Ellstein R, Zevallos RJ, Buckley JM, Souhrada JF. The beneficial effect of nasal breathing on exercise-induced bronchoconstriction. Am Rev Respir Dis. 1978;118:65-73.
15. Wilber RL, Rundell KW, Szmedra L, Jenkinson DM, Im J, Drake SD. Incidence of exercise-induced bronchospasm in Olympic winter sport athletes. Med Sci Sports Exerc. 2000;32:732-7.
16. Karjalainen EM, Laitinen A, Sue-Chu M, Altraja A, Bjermer L, Laitinen LA. Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine. Am J Respir Crit Care Med. 2000;161:2086-91.
17. Maiolo C, Fuso L, Todaro A, Anatra F, Boniello V, Basso S, et al. Prevalence of asthma and atopy in italian olympic athletes. Int J Sports Med. 2004;25:139-44.
18. Global Initiative for asthma (GINA). Global strategy for asthma management and prevention. Bethesda MD. National Health Institute (NHI) publication number 02-3659. 2002.
19. Bousquet J, Vignola A, Leynaert B, Demoly P. Links between rhinitis and asthma. Allergy. 2003;58:733-41.
20. Chánez P, Vignola AM, Vic P, Guddo F, Bonsignore G, Godard P, et al. Comparison between nasal and bronchial inflammation in asthmatic and control subjects. Am J Respir Crit Care Med. 1999; 159:588-95.
21. Bousquet J, Jacot W, Vignola A, Bachert C, Van Cawenberge P. Allergic rhinitis: a disease remodeling the upper airways? J Allergy Clin Immunol. 2004;113:43-9.
22. Corren J, Adinoff A, Irvin C. Changes in bronchial responsiveness following nasal provocacation con allergen. J Allergy Clin Immunol. 1992;89:611-8.
23. Schumacher M, Cota K, Taussig L. Pulmonary response to nasal-challenge testing of atopic subjects with stable asthma. J Allergy Clin Immunol. 1986;78:30-5.
24. Littell N, Carlisle C, Millman R, Braman S. Changes in airway resistance following nasal provocation. Am Rev Respir Dis. 1990; 141:580-3.
25. Togias A. Systemic immunologic and inflammatory aspects of allergic rhinitis. J Allergy Clin Immunol. 2000;106:S247-S50.
26. McCusker C, Chicoine M, Hamid D, Mazer B. Site-specific sensitization in a murine model of allergic rhinitis: role of the upper airway in lower airway disease. J Allergy Clin Immunol. 2002; 110:891-8.
27. Braunstahl GJ, Overbeek SE, KleinJan A, Prins JB, Hoogsteden HC, Fokkens WJ. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol. 2001;107:469-76.
28. Beeh KM, Beier J, Kornmann O, Meier C, Taeumer T, Buhl R. A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic with seasonal allergic rhinitis: correlation with plasma interleukin-5. Clin Exp Allergy. 2003;33: 475-82.
29. Chakir J, Laviolette M, Turcotte H, Boutet M, Boulet LP. Cytokine expression in the lower airways of nonasthmatics subjects with allergic rhinitis: influence of natural allergen exposure. J Allergy Clin Immunol. 2000;106:904-10.
30. Boulay ME, Boulet LP. Influence of natural exposure to pollen and domestic animals on airway responsiveness and inflammation in sensitized non-asthmatics subjects. Int Arch Allergy Immunol. 2002;128:336-43.
31. Braunstahl GJ, Fokkens WJ, Overbeek SE, KleinJan A, Hoogsteden HC, Prins JB. Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: a comparison between upper and lower airways. Clin Exp Allergy. 2003;33:579-87.
32. Boulay ME, Boulet LP. Lower airway inflammatory responses to repeated very low dose allergen challenge in allergic rhinitis and asthma. Clin Exp Allergy. 2002;32:1441-7.
33. Braunstahl GJ, KleinJan A, Overbeek SE, Prins JB, Hoogsteden HC, Fokkens WJ. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med. 2000;161:2051-7.
34. Braunstahl GJ, Overbeek SE, Fokkens WJ, KleinJan A, McEuen AR, Walls AF, et al. Segmental bronchoprovocation in allergic rhinitis affects mast cell and basophil numbers in nasal and bronchial mucosa. Am Respir Crit Care Med. 2001;164: 858-65.
35. McFadden ER Jr. Exercise-induced airway narrowing. En: Adkinson NF, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FE, editors. Middleton's allergy principles and practice. Philadelphia: Mosby Inc.; 2003. p. 1323-32.
36. Richardson HB, Slebohm PM. Nasal airway response to exercise. J Allergy. 1968;41:269-84.
37. Syabbalo NC, Bundgaard A, Widdicombe JG. Effect of exercise on nasal airflow resistance in healthy subjects and in patients with asthma and rhinitis. Bull Eur Physiopathol Respir. 1985;21:507-13.
38. Olson LG, Strohl KP. The response of the nasal airway to exercise. Am Rev Respir Dis. 1987;135:356-9.
39. Serra-Batlles J, Montserrat JM, Mullol J, Ballester E, Xaubet A, Picado C. Response of the nose to exercise in healthy subjects and in patients with rhinitis and asthma. Thorax. 1994;49:128-32.
40. Jang YJ, Lee JH, Jang JY. Acoustic rhinometric evaluation of the nasal response to exercise in patients with nasal septal deviation. Clin Otolaryngol. 2000;25:423-7.
41. Strohl KP, Arnold JL, Decker MJ, Hooekje PL, Doershuk CF, Stern RC. The nasal response to exercise in patients with cistic fibrosis. Rhinology. 1992;30:241-8.
42. Harlin SL, Ansel DG, Lane SR, Myers J, Kephart GM, Gleich GJ. A clinical and pathologic study of chronic sinusitis: the role of the eosinophil. J Allergy Clin Immunol. 1988;81:867-75.
43. Hamilos DL, Leung DY, Wood R, Meyers A, Stephens JK, Barkans J, et al. Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3. J Allergy Clin Immunol. 1993;92:39-48.
44. Jankowski R, Bouchoua F, Coffinet L, Vignaud JM. Clinical factors influencing the eosinophil infiltration of nasal polyps. Rhinology. 2002;40:173-8.
45. Bresciani M, Paradis L, Des Roches A, Vernhet H, Vachier I, Godard P, et al. Rhinosinusitis in severe asthma. J Allergy Clin Immunol. 2001;107:73-80.
46. Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2002;89:474-8.
47. Altamura Namazy J, Simon RA, Sensitivity to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol. 2002;89: 542-50.
48. Nguyen LHP, Manoukian JJ, Sobol SE, Tewfik TL, Mazer BD, Schloss MD, et al. Similar allergic inflammation in the middle ear and the upper airway: evidence linking otitis media with effusion to the united airways concept. J Allergy Clin Immunol. 2004; 114:1110-5.
49. Kaufman J, Wright G. The effect of nasal and nasopharyngeal irritation on airway resistance in man. Am Rev Respir Dis. 1969;100: 626-30.
50. Kaufman J, Chen J, Wright G. The effect of trigeminal resection on reflex bronchoconstriction after nasal and nasopharyngeal irritation in man. Am Rev Respir Dis. 1970;101:768-9.
51. Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol. 2003;111:1171-83.
52. Bardin P, Van Heerden B, Joubert J. Absence of pulmonary aspiration of sinus contents in patients with asthma and sinusitis. J Allergy Clin Immunol. 1990;86:82-8.
53. Csoma Z, Kharitonov S, Balint B, Bush A, Wilson N, Barnes P. Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med. 2002;166:1345-9.
54. Togias A, Bieneman A, Bloom D, Schleimer R, Lezzoni D, Harris A, et al. Changes in blood leucocyte cytokine expression following repeated nasal allergen provocation: evidence for systemic manifestations. J Allergy Clin Immunol. 2002;109:262.
55. Magnusson J, Ping Lin X, Dahlman-Höglund A, Hanson LA, Telemo E, Magnusson O, et al. Seasonal intestinal inflammation in patients with birch pollen allergy. J Allergy Clin Immunol. 2003; 112:45-51.
56. Sandrini A, Ferreira IM, Jardim JR, Zamel N, Chapman KR. Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis. J Allergy Clin Immunol. 2003;111:313-20.
57. Pedersen B, Dahl R, Lindqvist N, Mygind N. Nasal inhalation of the glucocorticoid budesonide from a spacer for the treatment of patients with pollen rhinitis and asthma. Allergy. 1990;45: 451-6.
58. Watson WT, Becker AB, Simons FE. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol. 1993;91:97-101.
59. Adams RJ, Fuhlbrigge AL, Finkelstein JA, Weiss ST. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol. 2002;109:636-42.
60. Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma related hospitalizations and emergency department visits. J Allergy Clin Immunol. 2002;109:57-62.
61. Pinto JM, Assanasen P, Barody FN, Naureckas E, Solway J, Naclerio RM. Treatment of nasal inflammation decreases the ability of subjects with asthma to condition inspired air. Am J Respir Crit Care Med. 2004;170:863-9.
62. Grant JA, Nicodemus CF, Findlay SR, Glovsky MM, Grossman J, Kaiser H, et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized controlled trial. J Allergy Clin Immunol. 1995;95:923-32.
63. Corren J, Harris AG, Aaronson D, Beaucher W, Berkowitz R, Bronsky E, et al. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and asthma. J Allergy Clin Immunol. 1997;100:781-8.
64. Ciprandi G, Tosca MA, Passalacqua G, Canonica GW. Long-term cetirizine treatment reduces allergic symptoms and drug prescriptions in children with mite allergy. Ann Allergy Asthma Immunol. 2001;87:222-6.
65. Baena-Cagnani CE, Berger WE, DuBuske LM, Gume SE, Stryszak P, Lorber R, et al. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol. 2003;130:307-13.
66. Abramson MJ, Puy RM, Weiner JM. Inmunoterapia con alergenos para el asma. En: La Cochrane Library plus en espanol. Oxford: Update Software. CD001186-ES; 2003.
67. Wilson DR, Torres Lima M, Durham SR. Inmunoterapia sublingual para la rinitis alérgica. En: La Cochrane Library plus en español. Oxford: Update Software. CD002893-ES; 2003.
68. WHO Position Paper: allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy. 1998;53 Suppl:1-42.
69. Moller C, Dreborg S, Ferdousi HA, Halken S, Host A, Jacobsen L, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol. 2002;109:251-6.
70. Vignola AM, Humbert M, Bousquet J, Boulet LP, Hedgecock S, Blogg M, et al. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Allergy. 2004; 59:709-17.
71. Passalacqua G, Canonica GW. Treating the allergic patient: think globally, treat globally. Allergy. 2002;57:876-83.